Author

Eric S. Wang

Sanford Burnham Prebys Medical Discovery InstituteORCID 0000-0002-6250-9748Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Alyssa L. VeranoiD· 1 shared Andrew M. LowyiD· 1 shared Anne G. BangiD· 1 shared Cara R. SchiavoniD· 1 shared Chun‐Teng HuangiD· 1 shared David A. ScottiD· 1 shared Elena RebolloiD· 1 shared Fleur M. FergusoniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alyssa L. VeranoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ZBTB11 Depletion Targets Metabolic Vulnerabilities in K-Ras Inhibitor Resistant PDAC

Nathan L. Tran, Jiewei Jiang, Mengyao Ma, Gillian E. Gadbois, Kevin Christian Montecillo Gulay, Alyssa L. Verano, Cara R. Schiavon, Elena Rebollo, Haowen Zhou, Chun‐Teng Huang, Rabi Murad, David A. Scott, Uri Manor, Anne G. Bang, Hervé Tiriac, , Fleur M. Ferguson

This study develops ZBTB11 degraders to target metabolic vulnerabilities in K-Ras inhibitor-resistant PDAC, showing improved anti-cancer activity with reduced toxicity to neurons.

Nature Chemical Biology · Aug 11, 2025Peer-reviewedCancer Biology